Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AGE NYSE:MCS NASDAQ:PSM CVE:RAK NYSE:SB On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAGEAgeX Therapeutics$4.54$11.07▼$35.71$11.99M1.183,849 shs3,700 shsMCSMarcus$15.90-0.6%$15.97$14.13▼$23.16$500.66M1.22211,714 shs174,824 shsPSMPrincipal U.S. Small-MidCap Multi-Factor ETF$29.53$29.53$15.33▼$29.53$11.81MN/A921 shsN/ARAKRackla MetalsC$0.84C$0.69C$0.08▼C$1.00C$131.68M-0.128394562,049 shs1.06 million shsSBSafe Bulkers$4.57+0.1%$4.25$3.02▼$5.24$466.58M1.3327,607 shs226,763 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAGEAgeX Therapeutics0.00%0.00%0.00%0.00%0.00%MCSMarcus-0.53%+2.52%+5.21%-7.37%+6.97%PSMPrincipal U.S. Small-MidCap Multi-Factor ETF0.00%0.00%0.00%0.00%0.00%RAKRackla Metals0.00%+1.20%+29.23%+162.50%+1,020.00%SBSafe Bulkers-0.11%+2.01%+5.67%+19.04%-4.50%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAGEAgeX Therapeutics$4.54$11.07▼$35.71$11.99M1.183,849 shs3,700 shsMCSMarcus$15.90-0.6%$15.97$14.13▼$23.16$500.66M1.22211,714 shs174,824 shsPSMPrincipal U.S. Small-MidCap Multi-Factor ETF$29.53$29.53$15.33▼$29.53$11.81MN/A921 shsN/ARAKRackla MetalsC$0.84C$0.69C$0.08▼C$1.00C$131.68M-0.128394562,049 shs1.06 million shsSBSafe Bulkers$4.57+0.1%$4.25$3.02▼$5.24$466.58M1.3327,607 shs226,763 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAGEAgeX Therapeutics0.00%0.00%0.00%0.00%0.00%MCSMarcus-0.53%+2.52%+5.21%-7.37%+6.97%PSMPrincipal U.S. Small-MidCap Multi-Factor ETF0.00%0.00%0.00%0.00%0.00%RAKRackla Metals0.00%+1.20%+29.23%+162.50%+1,020.00%SBSafe Bulkers-0.11%+2.01%+5.67%+19.04%-4.50%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAGEAgeX Therapeutics 0.00N/AN/AN/AMCSMarcus 3.25Buy$24.5054.13% UpsidePSMPrincipal U.S. Small-MidCap Multi-Factor ETF 0.00N/AN/AN/ARAKRackla Metals 0.00N/AN/AN/ASBSafe Bulkers 3.00Buy$4.47-2.15% DownsideCurrent Analyst Ratings BreakdownLatest SB, MCS, AGE, PSM, and RAK Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/4/2025MCSMarcusBarrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$25.007/18/2025MCSMarcusWedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$24.007/18/2025MCSMarcusWedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$24.00(Data available from 9/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAGEAgeX Therapeutics$140K0.00N/AN/A($16.07) per share0.00MCSMarcus$775.79M0.64$2.45 per share6.50$14.70 per share1.08PSMPrincipal U.S. Small-MidCap Multi-Factor ETFN/AN/AN/AN/AN/AN/ARAKRackla MetalsN/AN/AC$0.09 per share9.60C$0.05 per shareN/ASBSafe Bulkers$307.63M1.52$1.34 per share3.41$7.79 per share0.59Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAGEAgeX Therapeutics-$14.80M-$13.03N/AN/AN/A-10,424.65%N/A-120.90%N/AMCSMarcus-$7.79M$0.4535.3234.562.931.91%4.28%1.88%10/30/2025 (Estimated)PSMPrincipal U.S. Small-MidCap Multi-Factor ETFN/AN/A0.00∞N/AN/AN/AN/AN/ARAKRackla Metals-C$4.52M-C$0.03N/A∞N/AN/A-121.88%-65.75%N/ASBSafe Bulkers$97.38M$0.4310.627.87N/A19.25%5.80%3.45%11/12/2025 (Estimated)Latest SB, MCS, AGE, PSM, and RAK EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/1/2025Q2 2025MCSMarcus$0.19$0.23+$0.04$0.23$192.79 million$206.04 million7/29/2025Q2 2025SBSafe Bulkers$0.08$0.01-$0.07$0.02$60.40 million$65.75 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAGEAgeX TherapeuticsN/AN/AN/AN/AN/AMCSMarcus$0.322.01%N/A71.11%2 YearsPSMPrincipal U.S. Small-MidCap Multi-Factor ETF$0.431.46%N/AN/AN/ARAKRackla MetalsN/AN/AN/AN/AN/ASBSafe Bulkers$0.204.38%N/A46.51%N/ALatest SB, MCS, AGE, PSM, and RAK DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/5/2025MCSMarcusquarterly$0.082.15%8/25/20258/25/20259/15/20257/29/2025SBSafe Bulkersquarterly$0.055.2%8/21/20258/21/20259/5/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAGEAgeX TherapeuticsN/A0.130.36MCSMarcus0.400.390.39PSMPrincipal U.S. Small-MidCap Multi-Factor ETFN/AN/AN/ARAKRackla Metals0.334.576.93SBSafe Bulkers0.601.701.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAGEAgeX Therapeutics12.50%MCSMarcus81.57%PSMPrincipal U.S. Small-MidCap Multi-Factor ETFN/ARAKRackla Metals1.67%SBSafe Bulkers21.69%Insider OwnershipCompanyInsider OwnershipAGEAgeX Therapeutics6.50%MCSMarcus5.00%PSMPrincipal U.S. Small-MidCap Multi-Factor ETFN/ARAKRackla Metals13.48%SBSafe Bulkers40.25%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAGEAgeX Therapeutics51.08 million1.01 millionNot OptionableMCSMarcus8,55031.31 million29.75 millionOptionablePSMPrincipal U.S. Small-MidCap Multi-Factor ETFN/A400,000N/ANot OptionableRAKRackla Metals28,300156.76 millionN/ANot OptionableSBSafe Bulkers920102.32 million61.14 millionOptionableSB, MCS, AGE, PSM, and RAK HeadlinesRecent News About These CompaniesGoldman Sachs Group Inc. Acquires 91,662 Shares of Safe Bulkers, Inc $SBSeptember 17 at 3:45 AM | marketbeat.comSafe Bulkers, Inc. Announces Results of 2025 Annual Meeting of StockholdersSeptember 16 at 4:05 PM | globenewswire.comAmerican Century Companies Inc. Sells 510,744 Shares of Safe Bulkers, Inc $SBSeptember 1, 2025 | marketbeat.comSafe Bulkers, Inc (NYSE:SB) Shares Sold by Connor Clark & Lunn Investment Management Ltd.August 18, 2025 | marketbeat.comSafe Bulkers (SB) Q2 Revenue Beats Estimates, EPS DisappointsAugust 13, 2025 | insidermonkey.comSafe Bulkers Sells Kamsarmax Vessel as Part of Fleet Renewal StrategyAugust 13, 2025 | msn.comSafe Bulkers completes sale of oldest Kamsarmax vesselsAugust 13, 2025 | msn.comSafe Bulkers enters agreement for sale of MV Pedhoulas MerchantAugust 12, 2025 | msn.comSafe Bulkers, Inc. Announces Sale of a 2006-Built Kamsarmax Class Dry-bulk Vessel | SB Stock NewsAugust 12, 2025 | gurufocus.comSafe Bulkers, Inc. Announces Sale of MV Pedhoulas Merchant for $11.5 Million as Part of Fleet Renewal StrategyAugust 12, 2025 | quiverquant.comQSafe Bulkers, Inc. Announces Sale of a 2006-Built Kamsarmax Class Dry-bulk VesselAugust 12, 2025 | gurufocus.comSafe Bulkers, Inc. Announces Sale of a 2006-Built Kamsarmax Class Dry-bulk VesselAugust 12, 2025 | globenewswire.comSafe Bulkers Inc. Navigates Mixed Earnings CallAugust 12, 2025 | theglobeandmail.comInstitutional investors own a significant stake of 31% in Safe Bulkers, Inc. (NYSE:SB)August 5, 2025 | finance.yahoo.comSafe Bulkers Inc. Reports Q2 2025 EarningsJuly 31, 2025 | msn.comSafe Bulkers Announces 2025 Annual Meeting of StockholdersJuly 30, 2025 | theglobeandmail.comSafe Bulkers Declares Quarterly Dividend for Preferred SharesJuly 30, 2025 | theglobeandmail.comSafe Bulkers, Inc. (SB) Q2 2025 Earnings Call TranscriptJuly 30, 2025 | seekingalpha.comSafe Bulkers, Inc. Reports Second Quarter 2025 Results and Declares Dividend on Common StockJuly 29, 2025 | manilatimes.netMSafe Bulkers (SB) Q2 Earnings and Revenues Lag EstimatesJuly 29, 2025 | zacks.comSafe Bulkers Q2 2025 Earnings PreviewJuly 28, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesShould You Join Buffett and Invest in Constellation Brands?By Jordan Chussler | August 22, 2025BJ’s Wholesale Club Pulls Back to Trend: It’s Time for an EntryBy Thomas Hughes | August 25, 2025Buffett’s Cash Hoard Signals Market Caution, Value Plays EmergeBy Gabriel Osorio-Mazilli | August 19, 2025New Age Warfare: Anduril Is the Hype, AeroVironment Is the BuyBy Jeffrey Neal Johnson | August 28, 2025Why Sprouts Farmers Market is Buying $1 Billion of Its Own StockBy Gabriel Osorio-Mazilli | August 25, 2025SB, MCS, AGE, PSM, and RAK Company DescriptionsAgeX Therapeutics NYSE:AGEAgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead small molecule drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550 (Renelon), a gene delivery technology. AgeX Therapeutics, Inc. has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. The company was incorporated in 2017 and is based in Alameda, California.Marcus NYSE:MCS$15.90 -0.09 (-0.59%) Closing price 09/17/2025 03:59 PM EasternExtended Trading$15.92 +0.02 (+0.15%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Marcus Corporation, together with its subsidiaries, owns and operates movie theatres, and hotels and resorts in the United States. It operates a family entertainment center and multiscreen motion picture theatres under the Big Screen Bistro, Big Screen Bistro Express, BistroPlex, and Movie Tavern by Marcus brand names. The company also owns and operates full-service hotels and resorts, as well as manages full-service hotels, resorts, and other properties. In addition, it provides hospitality management services, including check-in, housekeeping, and maintenance for a vacation ownership development; and manages condominium hotels under long-term management contracts. The Marcus Corporation was founded in 1935 and is headquartered in Milwaukee, Wisconsin.Principal U.S. Small-MidCap Multi-Factor ETF NASDAQ:PSMRackla Metals CVE:RAKC$0.84 0.00 (0.00%) As of 09/17/2025 03:59 PM EasternRackla Metals Inc., a junior gold exploration company, engages in the acquisition, exploration, and evaluation of mineral properties in Canada. The company holds a 100% interest in the Rivier property located in the Watson Lake Mining District, Yukon. It also holds interests in the Tombstone Gold Belt projects situated in Yukon and Northwest Territories. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.Safe Bulkers NYSE:SB$4.57 +0.01 (+0.11%) Closing price 09/17/2025 03:59 PM EasternExtended Trading$4.58 +0.02 (+0.42%) As of 05:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Safe Bulkers, Inc., together with its subsidiaries, provides marine drybulk transportation services. It owns and operates drybulk vessels for transporting bulk cargoes primarily coal, grain, and iron ore. The company has a fleet of 47 drybulk vessels having an aggregate carrying capacity of 4,719,600 deadweight tons. Its fleet consists of 10 Panamax class vessels, 11 Kamsarmax class vessels, 18 post-Panamax class vessels, and 8 Capesize class vessels. Safe Bulkers, Inc. was incorporated in 2007 and is based in Monaco. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike’s Red-Hot Analyst Buzz: Is a Comeback Brewing? The Side of Rate Cuts Nobody Is Telling You About Broadcom Hits Record High After CEO Hock Tan AI Pay Package CrowdStrike Stock Set for Breakout as Agentic AI Demand Surges Why CoreWeave's NVIDIA Deal Creates a Deep Moat for AI Investors Dave & Buster’s Stock: Is Now the Time to Make a PLAY? Resideo Technologies: Institutional Activity Signals 30% Upside This Stock Quietly Benefits From Oracle and NVIDIA’s AI Surge Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.